-------------------- Revolutionary --------------------
The Rite Of Wealth
Over half a century ago, in New York City, three young men walked into a room.
90 minutes later, the door opened
The men emerged, shook hands, headed their separate ways and set about making stock market history.
The three men didn't stumble upon this room by chance.
They'd heard about it from other investors who were also using its secret to grow their wealth exponentially.
Since 1927 this room has held the key to banking huge returns from the stock market, because any investor who enters it goes through what I call the "Rite of Wealth".
Today I'm giving you the opportunity to access this secret, simply click here now for all the details...
MTN today is very different from MTN six months ago
There is no question MTN was due for a sell-off. And perhaps the -36% drop last year was justified. After all, the standard telecommunications business model is under pressure.
We’re seeing structural changes to the way telco companies make money. Revenue from “voice” is declining rapidly, although this is being offset to some degree by an increase in data consumption.
Group margins declined by 3.5% in FY2015. This was exacerbated by MTN Nigeria’s decline of 5.6%. Remember MTN Nigeria makes up almost half of group earnings. But, while some argue demand in Nigeria is under pressure, the biggest risk factor has been the regulatory environment. Investors are rightly concerned about a company operating in a country where the regulator can dish out fines of $5.2bn for failing to switch off unregistered mobile phone customers.
But the best opportunity is often found in adversity. Looking at the true mega-wealth created over history more often than not it was created in frontier markets. Look at Rockefeller, Carnegie even South Africa’s De Beer family. And, while the frontier is full of risk it’s also where fortunes are made.
So why should we bet on a turn-around in a frontier telco like MTN?
Iran Sanctions have been lifted – the removal of sanctions in Iran will see significant opportunities to expand digital and EBU services to the existing 46.1 million subscribers which showed 90.2% growth in data revenue for FY2015.
MTN is also working towards remittance of approximately R15.9 billion in the first half of 2016. This will help to maintain the R7 per share dividend guidance by management.
----------------- Limited Seats Available -----------------
Want to invest in penny shares, but don’t know where to start?
I’m sure you’ve read most of my articles on why penny shares are such a great investment.
Returns are exceptional and unrivalled in the investment world. But where do you start and how can you ensure that you pick a winning share?
That’s where I come in! On the 30th of July I’m giving 100 lucky readers in-depth training on how to get started in the exciting world of penny shares and, more importantly, how to pick the next ten-bagger. All of this information is exclusively available at my event and you don’t want to miss out on this opportunity.
Click here to book your ticket…
Nigerian fine squashed and the peg lifted – The monolithic $5.2bn fine hanging over the share in 2015 has, with the help of former US Attorney General Eric Holder, been revised down to just 330 billion naira. That equates to just over $1 billion at today’s exchange rate. Since the announcement we’ve seen a limited reaction from markets as Brexit and other macro concerns took center stage.
The removal of the Nigerian currency peg and the naira’s move to a free floating currency is very positive for the Nigerian economy longer-term. It has also lessened the fine in dollar terms (although we also expect there to be a translational effect on rand reported earnings).
The unpegging will go a long way to solving the USD liquidity issues facing the country.
The potential listing of MTN Nigeria on the NSE should enhance and broaden the depth of participation by Nigerian investors. This local ownership will likely reduce the political will to see future regulatory fines implemented.
New management team to guide growth – The appointment of experienced ex-investment bankers will help to shake off MTN’s reputation as a stock with limited growth prospects. Already there is speculation this could signal a move by the company into the fintech space.
Fintech has proven to be a resilient revenue stream for rivals such as Safaricom and a move in this direction is likely to increase group profitability.
The share price has a higher margin of safety relative to peers – With a 230 million plus subscriber base, MTN is four times the size of its biggest rival in Vodacom, yet at current market capitalization, the companies are worth around the same amount.
The reason: MTN stock is a lot cheaper than Vodacom. MTN trades on a forward multiple of 11.81x while Vodacom sits on 17.13x forward earnings.
With all the changes taking place we believe MTN has far greater prospects over the longer term period. This company is by no means risk free but we believe most of the downside is currently priced while significant upside remains.
------------------ Trust holders take note ------------------
Do you know how to complete the new income tax return for trusts?
SARS has introduced a new form for you to fill out on eFiling if you have a trust.
Completing the new Income Tax Return for Trusts (ITR12T) can be a mission especially when you consider the fact that the new ITR12T requires more information than the previous one did.
This means mistakes can easily creep in. But they don’t have to.
Here’s how to take the hassle out completing the new ITR12T form…
Aspen re-jigs its debt
Aspen is South Africa’s largest supplier of branded and generic pharmaceuticals and is active in more than 150 countries across the world. It also supplies consumer and nutritional products in selected territories. In 2015,
Aspen shareholders saw a significant re-rating in the stock price. The stock fell -42% from its all-time high to the near-term low. Why the panic?
The collapse was primarily sparked by the strengthening US dollar. Last year’s USD rally was a double-edged sword for Aspen, increasing its net financing cost on USD denominated debt as well as pushing up USD based input costs.
This eroded free cash flows and lowered the expectations of future earnings. As a result of the counter shifted from trading at a 43x historic earnings to the current 26x. But this re-rating could soon become a blip on Aspen’s otherwise uninterrupted upward trajectory.
Aspen has announced the refinancing of the debt package. Aspen’s debt has been an issue for investors over the last 18 months, as the bulk of the initial debt was USD denominated with almost no sales in the US. Most of the company’s international sales are in euros.
While not yet announced, we can safely assume the new interest rate on this new debt package is significantly more favourable than the old US debt package.
Aspen’s management team has almost doubled the group’s revenue every five years. This dynamic team is known for their ability to do unbelievable deals. After a quiet patch, corporate activity has ramped up in the past few months.
The agreement with AstraZeneca fits well with the group’s strategy to expand into complementary “niche” categories. This latest acquisition is strongly earnings accretive and our sell-side analyst estimates this will add a further R1 billion to operating profits in FY2017.
------------------ Sale Ends Soon ------------------
My one day Forex 101 Workshop is
not just about teaching you how to start trading…
I’ll give you all the tools, tips and secrets you need to succeed as a private Forex trader - so you can make money quickly.
I'll walk you through the start-up process and show you how the charts work. This isn’t a mystery you need to be afraid of. Anyone can do it!
Together we’ll implement the techniques I've used and perfected over the decade to make money quickly.
I urge you to secure your seat today at my Forex 101 Workshop TODAY.
The acquisition of the intellectual property of Hydroxyprogesterone Corporate (HPC) will provide an exclusive distribution and supply agreement with ANI Pharmaceuticals.
This will allow Aspen to supply the finished dose form and ANI will be responsible for marketing and distribution in the US. We believe that this product is likely to gain significant traction in the US market.
Aspen’s share price has held up well during the Brexit shock and looks to make new 52 weeks high as the group continues to offer investors exposure to a variety of geographies where it commands a strong market share.
We continue to back this exceptional management team to deliver superior returns through further suitable earnings-enhancing acquisitions and strong organic growth.
While these companies are not related from an operational point of view, both are large emerging market players. With a lot of uncertainty still surrounding the developed market thanks to “Brexit”, emerging markets plays could be net beneficiaries.
Most central banks have pledged further accommodative monetary policy measures. The Federal Fund futures are now actually pricing in the possibility of a rate cut in for the first time in 2016. And with developed market treasury yield curves flattening, it’s very possible capital will begin to flow back toward the emerging markets as investors hunt for returns.
All of this will be net positive for these unloved former market darlings.
Gary Booysen for The South African Investor
If you are interested in building up a portfolio of long-term equity in companies with economic moats the ones mentioned in this article – please do not hesitate to contact us directly.